Sourcebio International PLC
LSE:SBI
Sourcebio International PLC
LSE:SBI
Price:
115 GBX
4.55%
Market Closed
Updated:
May 15, 2024
Balance Sheet
Balance Sheet Decomposition
Sourcebio International PLC
Sourcebio International PLC
| Current Assets | 24.4m |
| Cash & Short-Term Investments | 15.2m |
| Receivables | 7.5m |
| Other Current Assets | 1.6m |
| Non-Current Assets | 56.3m |
| PP&E | 22.1m |
| Intangibles | 34.2m |
| Current Liabilities | 12.8m |
| Accounts Payable | 4.1m |
| Accrued Liabilities | 1.4m |
| Other Current Liabilities | 7.3m |
| Non-Current Liabilities | 21.9m |
| Long-Term Debt | 14.9m |
| Other Non-Current Liabilities | 7m |
Balance Sheet
Sourcebio International PLC
Sourcebio International PLC
Currency: GBP
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
1
|
1
|
1
|
8
|
33
|
|
| Cash Equivalents |
1
|
1
|
1
|
8
|
33
|
|
| Total Receivables |
6
|
6
|
5
|
10
|
7
|
|
| Accounts Receivables |
5
|
6
|
4
|
10
|
6
|
|
| Other Receivables |
1
|
1
|
1
|
0
|
1
|
|
| Inventory |
1
|
1
|
1
|
4
|
5
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
1
|
|
| Total Current Assets |
8
|
9
|
8
|
23
|
46
|
|
| PP&E Net |
11
|
9
|
11
|
16
|
19
|
|
| PP&E Gross |
11
|
9
|
11
|
16
|
19
|
|
| Accumulated Depreciation |
2
|
1
|
1
|
1
|
5
|
|
| Intangible Assets |
1
|
0
|
0
|
0
|
0
|
|
| Goodwill |
11
|
10
|
10
|
10
|
10
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
11
|
10
|
10
|
10
|
10
|
|
| Total Assets |
31
N/A
|
28
-10%
|
29
+3%
|
50
+74%
|
75
+50%
|
|
| Liabilities | ||||||
| Accounts Payable |
3
|
2
|
2
|
2
|
5
|
|
| Accrued Liabilities |
1
|
2
|
2
|
1
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
20
|
26
|
25
|
1
|
1
|
|
| Other Current Liabilities |
2
|
3
|
2
|
2
|
5
|
|
| Total Current Liabilities |
25
|
33
|
31
|
6
|
14
|
|
| Long-Term Debt |
62
|
64
|
75
|
12
|
12
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
2
|
1
|
1
|
1
|
0
|
|
| Total Liabilities |
89
N/A
|
97
+10%
|
106
+9%
|
18
-83%
|
27
+47%
|
|
| Equity | ||||||
| Common Stock |
3
|
3
|
3
|
0
|
0
|
|
| Retained Earnings |
0
|
72
|
80
|
2
|
15
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
33
|
33
|
|
| Other Equity |
60
|
0
|
0
|
0
|
0
|
|
| Total Equity |
57
N/A
|
69
-20%
|
77
-12%
|
32
N/A
|
48
+52%
|
|
| Total Liabilities & Equity |
31
N/A
|
28
-10%
|
29
+3%
|
50
+74%
|
75
+50%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
74
|
74
|
74
|
74
|
74
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
